Ketamine Completed Phase 2 Trials for Major Depressive Disorder (MDD) / Alcohol Use Disorder (AUD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02078817Ketamine in Adolescents With Treatment-Resistant Depression
NCT03658330Naltrexone Plus Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder
NCT01627782A Study of Ketamine in Patients With Treatment-resistant Depression